Nivolumab trials for Breast cancer

All Nivolumab trials · All Breast cancer trials

Phase breakdown

Recruiting trials studying Nivolumab for Breast cancer

• Agnostic Therapy in Rare Solid Tumors
  NCT06638931 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
• Immune Induction Strategies to Improve Response to Immune Checkpoint Blockade in Triple Negative Breast Cancer (TNBC) Patients
  NCT04159818 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer
  NCT05098210 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Saci Nivo Rela for TNBC
  NCT06963905 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Trial of Therapies With IT cDC1s Combined w/ IT Trastuzamab for Her+ or IT Nivolumab for Her- BC LMD
  NCT07694986 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Nivolumab for Breast cancer?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.